RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Qing Li to Drug Synergism

This is a "connection" page, showing publications Qing Li has written about Drug Synergism.
Connection Strength

0.297
  1. Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by ?-elemene in resistant human ovarian cancer cells. Med Oncol. 2013 Mar; 30(1):424.
    View in: PubMed
    Score: 0.105
  2. Li QQ, Wang G, Reed E, Huang L, Cuff CF. Evaluation of cisplatin in combination with ?-elemene as a regimen for prostate cancer chemotherapy. Basic Clin Pharmacol Toxicol. 2010 Nov; 107(5):868-76.
    View in: PubMed
    Score: 0.090
  3. Liang G, Tang A, Lin X, Li L, Zhang S, Huang Z, Tang H, Li QQ. Green tea catechins augment the antitumor activity of doxorubicin in an in vivo mouse model for chemoresistant liver cancer. Int J Oncol. 2010 Jul; 37(1):111-23.
    View in: PubMed
    Score: 0.088
  4. McQuate GT, Keum YS, Sylva CD, Li QX, Jang EB. Active ingredients in cade oil that synergize attractiveness of alpha-ionol to male Bactrocera latifrons (Diptera: Tephritidae). J Econ Entomol. 2004 Jun; 97(3):862-70.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support